We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.06B
AUM Growth
+$107M
Cap. Flow
-$28.6M
Cap. Flow %
-1.39%
Top 10 Hldgs %
29.47%
Holding
2,720
New
413
Increased
568
Reduced
616
Closed
259

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$25.8M
2
BND icon
Vanguard Total Bond Market
BND
+$15M
3
LIN icon
Linde
LIN
+$7.79M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$6.97M
5
MDT icon
Medtronic
MDT
+$4.99M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$16.1M
2
AAPL icon
Apple
AAPL
+$3.64M
3
MSFT icon
Microsoft
MSFT
+$2.79M
4
AMZN icon
Amazon
AMZN
+$1.11M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$937K

Sector Composition

Rank Sector Weight
1 Technology 24.3%
2 Healthcare 11.82%
3 Financials 10.45%
4 Consumer Discretionary 9.39%
5 Industrials 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZIMV
2101
DELISTED
ZimVie
ZIMV
$14.4K ﹤0.01%
1,286
– –
UIS icon
2102
Unisys
UIS
$210M
$14.4K ﹤0.01%
3,614
– –
AROW icon
2103
Arrow Financial
AROW
$723M
$14.4K ﹤0.01%
735
– –
ICPT
2104
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$14.4K ﹤0.01%
1,298
– –
RYAM icon
2105
Rayonier Advanced Materials
RYAM
$570M
$14.3K ﹤0.01%
3,351
– –
EVC icon
2106
Entravision Communication
EVC
$820M
$14.3K ﹤0.01%
3,265
– –
ABUS icon
2107
Arbutus Biopharma
ABUS
$906M
$14.3K ﹤0.01%
6,209
– –
ZUMZ icon
2108
Zumiez
ZUMZ
$319M
$14.3K ﹤0.01%
857
– –
EOLS icon
2109
Evolus
EOLS
$530M
$14.2K ﹤0.01%
1,957
+755
+63% +$6.51K
NWPX icon
2110
NWPX Infrastructure Inc
NWPX
$1.11B
$14.2K ﹤0.01%
470
– –
REFI
2111
Chicago Atlantic Real Estate Finance
REFI
$264M
$14.2K ﹤0.01%
+935
New +$13.6K
SRTA
2112
Strata Critical Medical Inc
SRTA
$528M
$14.1K ﹤0.01%
3,584
+1,948
+119% +$6.18K
NRDY icon
2113
Nerdy
NRDY
$92.6M
$14.1K ﹤0.01%
3,377
+1,622
+92% +$5.76K
EPM icon
2114
Evolution Petroleum
EPM
$135M
$14K ﹤0.01%
+1,736
New +$12.8K
YMAB
2115
DELISTED
Y-mAbs Therapeutics
YMAB
$14K ﹤0.01%
2,055
– –
OLMA icon
2116
Olema Pharmaceuticals
OLMA
$920M
$14K ﹤0.01%
+1,545
New +$9.33K
CSTR
2117
DELISTED
CapStar Financial Holdings, Inc
CSTR
$14K ﹤0.01%
1,137
– –
CRBU icon
2118
Caribou Biosciences
CRBU
$160M
$13.9K ﹤0.01%
3,278
– –
BLNK icon
2119
Blink Charging
BLNK
$87.1M
$13.9K ﹤0.01%
2,320
– –
TYRA icon
2120
Tyra Biosciences
TYRA
$1.49B
$13.9K ﹤0.01%
814
– –
CGEM icon
2121
Cullinan Oncology
CGEM
$1.26B
$13.8K ﹤0.01%
1,286
-503
-28% -$5.34K
LOCO icon
2122
El Pollo Loco
LOCO
$471M
$13.8K ﹤0.01%
1,577
+473
+43% +$4.43K
TSP
2123
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$13.8K ﹤0.01%
8,331
– –
FET icon
2124
Forum Energy Technologies
FET
$927M
$13.8K ﹤0.01%
+540
New +$12.8K
FLIC
2125
DELISTED
First of Long Island Corp
FLIC
$13.8K ﹤0.01%
1,144
– –
83 84
85
86 87

Similar funds

GWM
Graybill Wealth Management Elmhurst, Illinois $328M AUM 21.42% 1-Year Est. Return
KSCM
King Street Capital Management New York $328M AUM 0.61% 1-Year Est. Return
AFS
Aft Forsyth & Sober Valrico, Florida $328M AUM 25.24% 1-Year Est. Return
BAM
Blueshift Asset Management Red Bank, New Jersey $330M AUM 7.9% 1-Year Est. Return
ML
Maniro Ltd Nassau $330M AUM
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return
ECH
ER Collective Holdings Washington, District of Columbia $326M AUM
PCM
Payne Capital Management New York $331M AUM 19.65% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 Portfolio in Review

As of Q2 2023, Metropolitan Life Insurance Company (MetLife) held 2,720 positions worth $2.06B, up 5.5% from $1.95B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 filing shows 413 new, 568 increased, 616 reduced and 259 closed positions. Its largest new stake was Alphabet (Google) Class C: 222,708 shares worth $26.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2023 buy was Alphabet (Google) Class C: 222,708 shares worth $26.9M.
  • Metropolitan Life Insurance Company (MetLife) added most to Vanguard Total Bond Market in Q2 2023, an estimated $15M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $16.1M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Iridium Communications in Q2 2023, selling an estimated $418K.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 29% of its $2.06B portfolio in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 413 new positions and closed 259 in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 5.5% quarter-over-quarter to $2.06B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.